 |
|
June 25, 2009
June 26, 2009
| 9:00 am |
OPENING |
| 9:45 am |
Session 1: STEM CELL & GENE REPAIR - Chair: Patrick AUBOURG - Inserm U-745, Paris, France |
9:45 am
10:30 am |
Keynote on neural stem cells - Steven A. Goldman - University of Rochester Medical Center, Rochester, NY, USA |
10:30 am
11:00 am
|
Coffee Break |
11:00 am
11:45 am |
Testing the efficacy of gene and neural stem cell therapy to treat Globoid Cell Leukodystrophy - Angela Gritti - HSR-TIGET, Fondazione San Raffaele del Monte Tabor, Milan, Italy |
11:45 am
12:30 am |
Zinc-finger nucleases and gene editing in human stem cells - Luigi Naldini - San Raffaele Telethon Institute for Gene Therapy, Milan, Italy |
| 12:30 pm |
Lunch and POSTER SESSION |
| 14:30 pm |
Session 2: BIOLOGY of MYELINATION/REMYELINATION - Chair: Robin FRANKLIN - Cambridge Centre for Brain Repair, University of Cambridge, United Kingdom |
14:30 pm
15:00 pm |
Oligodendroglial exosome secretion in axon-glia interaction - Eva-Maria Kramer-Albers - University of Mainz, Mainz, Germany |
15:00 pm
15:30 pm |
Using Brainbow multicolor transgenes to visualize cellular interactions in myelination/demyelination - Jean Livet - Institut de la Vision, Paris, France |
15:30 pm
16:00 pm
|
Focal experimental autoimmune encephalomyelitis in the Lewis rat immunized with rat MOG and focal spinal cord injection of VEGF - Jeffery Kocsis - Yale University School of Medicine, West Haven, CT, USA |
16:00 pm
16:30 pm |
Coffee Break |
16:30 pm
17:00 pm: |
Remyelination of the CNS: a valuable contribution from the periphery - Anne Baron-Van Evercooren Inserm U-975, Paris, France |
17:00 pm
17:30 pm: |
NMDA receptor blocking as therapeutic strategy for reducing damage in CNS white matter - Nicola Hamilton - University College London, London, UK) |
17:30 pm
19:00 pm
|
POSTER SESSION |
| 20:30 pm |
BANQUET |
June 27, 2009
| 9:00 am |
Session 3: COGNITIVE FUNCTIONS & DEMYELINATING DISORDERS - Chair: Odile BOESPFLUG-TANGUY - Inserm U-931, School of Medecine, Clermont Ferrand, France |
9:00 am
9:30 am |
Cognitive impairment in multiple sclerosis - Bruno Brochet - Hôpital Pellegrin, Bordeaux, France |
| 9:30 am
10:00 am: |
Cognitive impairment in Pelizaeus-Merzbacher Disease - Odile Boespflug-Tanguy - Inserm U-931, School of Medecine, Clermont Ferrand, France |
10:00 am
10:30 am: |
Axonal damage and language impairment - Hui Mao - Emory University School of Medicine, Atlanta, GA, USA |
10:30 am
11:00 am: |
Coffee Break |
| 11:00 am |
Session 4: NEUROIMAGING in CNS WHITE MATTER DISEASE - Chair: Kleopas KLEOPA - The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus |
11:00 am
12:00 am: |
Keynote on DTI, 3D reconstruction - Sheng-Kwei Song - Washington University, St. Louis, MI, USA |
12:00 am
12:30 am: |
Functional MRI in multiple sclerosis and related diseases - Massimo Filippi - Ospedale San Raffaele, Milan, Italy |
| 12:30 pm |
Lunch and POSTER SESSION |
| 14:15 pm |
Session 5: THERAPEUTICS - Chair: Aurora Pujol - Medical & Molecular Genetics Center, IDIBELL, L’Hospitalet de Llobregat, Spain |
14:15 pm
14:40 pm: |
General introduction to oxidative stress in neurodegeneration - Anatoly Starkov - Weill Cornell Medical College, New York, NY, USA |
14:40 pm
15:10 pm: |
Hematopoietic stem cell gene therapy in adrenoleukodystrophy - Nathalie Cartier-Lacave - Inserm U-745, Paris, France |
15:10 pm
15:35 pm: |
Hematopoietic stem cell gene therapy in metachromatic leukodystrophy - Alessandra Biffi - San Raffaele Telethon Institute for Gene Therapy, Milan, Italy |
15:35 pm
16:00 pm: |
Coffee Break |
16:00 pm
16:30 pm: |
Virus-mediated gene delivery to oligodendrocytes in vivo - Matthias Klugmann - University of Mainz, Mainz, Germany |
16:30 pm
17:00 pm: |
Experimental therapies of Pelizaeus-Merzbacher Disease - Michael Sereda - Max-Planck Institute of Experimental Medicine, Gottingen, Germany |
17:00 pm
17:30 pm: |
Intracerebral gene therapy in metachromatic leukodystrophy - Caroline Sevin - Inserm U-745, Paris, France |
17:30 pm
|
POSTER SESSION |
| 18:30 pm |
CLOSING |
|
|
| |
|
|
|
